Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × SCLC × 30 days × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 351 Neoplasms 256 Prostatic Neoplasms 213 Lung Neoplasms 152 Carcinoma, Non-Small-Cell Lung 128 Leukemia, Myeloid, Acute 120 Colorectal Neoplasms 118 Brain Neoplasms 93 Neoplasm Metastasis 87 Multiple Myeloma 85 Pancreatic Neoplasms 76 Melanoma 74 Carcinoma, Hepatocellular 72 Ovarian Neoplasms 68 Glioma 68 Precursor Cell Lymphoblastic Leukemia-Lymphoma 63 Glioblastoma 63 Squamous Cell Carcinoma of Head and Neck 60 Uterine Cervical Neoplasms 55 Head and Neck Neoplasms 55 Urinary Bladder Neoplasms 54 Sarcoma 53 Recurrence 52 Hematologic Neoplasms 50 Triple Negative Breast Neoplasms 49 Myelodysplastic Syndromes 49 Colonic Neoplasms 48 Lymphoma 45 Rectal Neoplasms 42 Carcinoma, Renal Cell 42

Interventions

Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07110103 2026-02-27

JACKPOT38

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡